RESEARCH ARTICLE
Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder
Hardoy Maria Carolina*, Carta Mauro Giovanni
Article Information
Identifiers and Pagination:
Year: 2010Volume: 6
First Page: 1
Last Page: 3
Publisher ID: CPEMH-6-1
DOI: 10.2174/1745017901006010001
Article History:
Received Date: 7/9/2009Revision Received Date: 1/11/2009
Acceptance Date: 1/11/2009
Electronic publication date: 27/1/2010
Collection year: 2010

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
The topic of early response to antidepressant treatment has been extensively studied in major depressive disorder (MDD). We serendipitous observed an increase tolerability, a rapid response to therapy and an early onset of antidepressant fluvoxamine activity when associated with amisulpride in patients with major depressive disorder. The purpose of this study was to investigate our preliminary observations.